Cassie Jung, Chief Operating Officer at Aquestive Therapeutics, Inc. (AQST), sold 91,582 shares at $4.17 ($382K) on 2026-03-10, disclosed to the SEC on 2026-03-11.
Seasonal sale ($382k) by Chief Operating Officer — this insider has traded AQST in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.17 | 45,791 | $191K | 50.0% |
| 2 | $4.17 | 45,791 | $191K | 50.0% |
| Total | $4.17 avg | 91,582 | $382K | 100% |
| Filing → |
| AQST | SELL | 2024-11-27 | $214 | — | Filing → |